AI is not a panacea for medical progress, particularly in the fight against diseases like Alzheimer’s. While it has potential to enhance drug design and improve diagnostics, significant bottlenecks in understanding disease mechanisms, trial participation, and public health initiatives still require attention and funding beyond AI capabilities. Investments in biomedical science and public health are essential for achieving meaningful advancements in medicine.